Conjunctival melanoma and melanocytic intra-epithelial neoplasia

Eye (Basingstoke)

Volumn 27, Issue 2, 2013, Pages 142-152

  Kenawy, N ^a   Lake, S L ^b   Coupland, S E ^b   Damato, B E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Conjunctiva; Genetics; Melanoma; Pathology; Prognosis; Treatment

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN; VEMURAFENIB;

AGE DISTRIBUTION; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL FEATURE; CONFERENCE PAPER; CONJUNCTIVA TUMOR; CONJUNCTIVAL MELANOCYTIC INTRAEPITHELIAL NEOPLASIA; CONJUNCTIVAL MELANOMA; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; MELANOMA; METASTASIS; PREVALENCE; PROTON THERAPY; SENTINEL LYMPH NODE BIOPSY;

EID: 84874072219     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.254     Document Type: Conference Paper

References (56)

1. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998;42(4): 321-350
2. Brownstein S. Malignant melanoma of the conjunctiva. Cancer Control 2004;11(5): 310-316
3. Grossniklaus H E, Green W R, Luckenbach M, Chan CC. Conjunctival lesions in adults. A clinical and histopathologic review. Cornea 1987;6(2): 78-116
4. Damato B, Coupland SE. Management of conjunctival melanoma. Expert Rev Anticancer Ther 2009;9(9): 1227-1239
5. Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) 2009;23(4): 801-809
6. Damato B, Coupland SE. Clinical mapping of conjunctival melanomas. Br J Ophthalmol 2008;92(11): 1545-1549
7. Edge S B, Byrd D R, Compton C C, Fritz A G, Greene F L, Trotti A (eds). Malignant melanoma of the conjunctiva In: AJCC Cancer Staging Manual, 7th edn. Springer New York, N Y, 2010, pp 539-546
8. Damato B, Coupland SE. Conjunctival melanoma and melanosis: A reappraisal of terminology, classification and staging. Clin Exp Ophthalmol 2008;36(8): 786-795
9. Shields J A, Shields C L, Mashayekhi A, Marr B P, Benavides R, Thangappan A et al. Primary acquired melanosis of the conjunctiva: Experience with 311 eyes. Trans Am Ophthalmol Soc 2007;105: 61-71;discussion 71-2
10. Shields J A, Shields C L, Mashayekhi A, Marr B P, Benavides R, Thangappan A et al. Primary acquired melanosis of the conjunctiva: Risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology 2008; 115(3): 511-519.e2
11. Jakobiec F A, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989;96(2): 147-166
12. Paridaens A D, McCartney A C, Hungerford JL. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol 1992;76(3): 163-165
13. Tuomaala S, Aine E, Saari K M, Kivela T. Corneally displaced malignant conjunctival melanomas. Ophthalmology 2002;109(5): 914-919
14. Jakobiec F A, Rini F J, Fraunfelder F T, Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology 1988;95(8): 1058-1070
15. ParidaensD, Beekhuis H, vanDen BoschW, Remeyer L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001;85(6): 658-661
16. Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol 2005;243(11): 1108-1114
17. Pe'er J, Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol 2005;139(2): 229-234
18. Finger P T, Sedeek R W, Chin KJ. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 2008;145(1): 124-129
19. Frucht-Pery J, Pe'er J. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996;114(10): 1261-1264
20. Folberg R, McLean I W, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol 1985;16(2): 136-143
21. Isager P, Osterlind A, Engholm G, Heegaard S, Lindegaard J, Overgaard J et al. Uveal and conjunctival malignant melanoma in Denmark, 1943-97: Incidence and validation study. Ophthalmic Epidemiol 2005;12(4): 223-232
22. Folberg R, McLean I W, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985;16(2): 129-135
23. Missotten G S, Keijser S, De Keizer R J, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: A nationwide study. Invest Ophthalmol Vis Sci 2005;46(1): 75-82
24. Shields C L, Fasiuddin A F, Mashayekhi A, Shields JA. Conjunctival nevi: Clinical features and natural course in 410 consecutive patients. Arch Ophthalmol 2004;122(2): 167-175
25. Kurli M, Finger PT. Melanocytic conjunctival tumors. Ophthalmol Clin North Am 2005;18(1): 15-24;vii
26. McDonnell J M, Carpenter J D, Jacobs P, Wan W L, Gilmore JE. Conjunctival melanocytic lesions in children. Ophthalmology 1989;96(7): 986-993
27. Shields C L, Shields J A, Gunduz K, Cater J, Mercado G V, Gross N et al. Conjunctival melanoma: Risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118(11): 1497-1507
28. Mohamed M D, Gupta M, Parsons A, Rennie IG. Ultrasound biomicroscopy in the management of melanocytoma of the ciliary body with extrascleral extension. Br J Ophthalmol 2005;89(1): 14-16
29. Kiratli H, Shields C L, Shields J A, DePotter P. Metastatic tumours to the conjunctiva: Report of 10 cases. Br J Ophthalmol 1996;80(1): 5-8
30. Paridaens A D, McCartney A C, Minassian D C, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 1994;78(7): 520-528
31. Tuomaala S, Kivela T. Sentinel lymph node biopsy guidelines for conjunctival melanoma. Melanoma Res 2008;18(3): 235
32. Esmaeli B. Regional lymph node assessment for conjunctival melanoma: Sentinel lymph node biopsy and positron emission tomography. Br J Ophthalmol 2008;92(4): 443-445
33. Savar A, Ross M I, Prieto V G, Ivan D, Kim S, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma: Experience in 30 patients. Ophthalmology 2009;116(11): 2217-2223
34. Morton D L, Thompson J F, Cochran A J, Mozzillo N, Elashoff R, Essner R et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355(13): 1307-1317
35. Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: Implications for sentinel lymph node biopsy. Ophthalmology 2004;111(4): 816-821
36. Esmaeli B, Wang X, Youssef A, Gershenwald JE. Patterns of regional and distant metastasis in patients with conjunctival melanoma: Experience at a cancer center over four decades. Ophthalmology 2001;108(11): 2101-2105
37. Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol 2012;153(4): 661-668
38. Shields J A, Shields C L, Gündüz K, Cater J. Clinical features predictive of orbital exenteration for conjunctival melanoma. Ophthal Plast Reconstr Surg 2000;16(3): 173-178
39. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: A retrospective study. Br J Ophthalmol 2002;86(2): 163-167
40. De Potter P, Shields C L, Shields J A, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: A review of 68 cases. Br J Ophthalmol 1993;77(10): 624-630
41. Desjardins L, Poncet P, Levy C, Schlienger P, Asselain B, Validire P. Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients. J Fr Ophtalmol 1999;22(3): 315-321
42. Paridaens A D, Minassian D C, McCartney A C, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: A clinicopathological study of 256 cases. Br J Ophthalmol 1994;78(4): 252-259
43. Tuomaala S, Toivonen P, Al-Jamal R, Kivelä T. Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 2007;32(11): 939-952
44. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: Terminology, classification, and biologic behavior. Hum Pathol 1986;17(7): 652-654
45. Lake S L, Jmor F, Dopierala J, Taktak A F, Coupland S E, Damato BE. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci 2011;52(8): 5598-5604
46. Populo H, Soares P, Rocha A S, Silva P, Lopes JM Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma. Melanoma Res 2010;20(2): 107-117
47. Busam K J, Fang Y, Jhanwar S C, Pulitzer M P, Marr B, Abramson DH. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J Cutan Pathol 2010;37(2): 196-203
48. Dratviman-Storobinsky O, Cohen Y, Frenkel S, Pe'er J, Goldenberg-Cohen N. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Invest Ophthalmol Vis Sci 2010;51(12): 6180-6182
49. Beadling C, Jacobson-Dunlop E, Hodi F S, Le C, Warrick A, Patterson J et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008;14(21): 6821-6828
50. Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D et al. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci 2005;46(9): 3027-3030
51. Gear H, Williams H, Kemp E G, Roberts F. BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci 2004;45(8): 2484-2488
52. Spendlove H E, Damato B E, Humphreys J, Barker K T, Hiscott P S, Houlston RS. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res 2004;14(6): 449-452
53. Vajdic C M, Hutchins A M, Kricker A, Aitken J F, Armstrong B K, Hayward NK et al. Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study. Cancer Genet Cytogenet 2003;144(1): 12-17
54. McNamara M, Felix C, Davison E V, Fenton M, Kennedy SM. Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization Cancer Genet Cytogenet 1997;98(1): 4-8
55. Dahlenfors R, Tornqvist G, Wettrell K, Mark J. Cytogenetical observations in nine ocular malignant melanomas. Anticancer Res 1993;13(5A): 1415-1420
56. Chapman P B, Hauschild A, Robert C, Haanen J B, Ascierto P, Larkin J et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364(26): 2507-2516